EUVIMEDEUVIMED entdecken
Crossref

Co-delivery of dasatinib and miR-30a by liposomes targeting neuropilin-1 receptors for triple-negative breast cancer therapy

Sahel Soghrati, Jaleh Varshosaz iD, Mahboubeh Rostami iD, Mina Mirian

Journal of Materials Chemistry B · 2025

DOI: 10.1039/d4tb02222j ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2025. Verfasst von Sahel Soghrati und 3 weiteren Autor:innen. Beteiligte Einrichtung: Novel Drug Delivery Systems Research Centre, Department of Pharmaceutics, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medic…. Hauptthemen laut MEDLINE: Dasatinib, Neuropilin-1, Triple Negative Breast Neoplasms, MicroRNAs. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: Isfahan University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted co-delivery of dasatinib and miR30a polyplexes by CRGDK-decorated liposomes dramatically improved the inhibition of cell proliferation and invasion of TNBC cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DasatinibNeuropilin-1Triple Negative Breast NeoplasmsMicroRNAsDrug Delivery SystemsLiposomesHumansCell Line, TumorFemaleParticle SizeCell SurvivalWound HealingApoptosisDeoxyribonuclease IInhibitory Concentration 50MethacrylatesPolymersPeptides, Cyclic

Substanzen

DasatinibLiposomesNeuropilin-1MicroRNAsDeoxyribonuclease IMIRN30a microRNA, humanpoly(2-aminoethyl methacrylate)MethacrylatesPolymerscyclic (arginyl-glycyl-aspartyl-phenylalanyl-lysyl)

Autor:innen und Institutionen

  • Novel Drug Delivery Systems Research Centre, Department of Pharmaceutics, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran. varshosaz@pharm.mui.ac.ir.
  • Novel Drug Delivery Systems Research Centre and Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Department of Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.

ORCID-Profile: Jaleh Varshosaz, Mahboubeh Rostami

Förderung

  • Isfahan University of Medical Sciences

Zitieren

APA

Soghrati, S., Varshosaz, J., Rostami, M., & Mirian, M. (2025). Co-delivery of dasatinib and miR-30a by liposomes targeting neuropilin-1 receptors for triple-negative breast cancer therapy. Journal of Materials Chemistry B. https://doi.org/10.1039/d4tb02222j

Vancouver

Soghrati S, Varshosaz J, Rostami M, Mirian M. Co-delivery of dasatinib and miR-30a by liposomes targeting neuropilin-1 receptors for triple-negative breast cancer therapy. Journal of Materials Chemistry B. 2025. doi:10.1039/d4tb02222j

BibTeX
@article{Soghrati2025,
  author = {Soghrati, Sahel and Varshosaz, Jaleh and Rostami, Mahboubeh and Mirian, Mina},
  title = {Co-delivery of dasatinib and miR-30a by liposomes targeting neuropilin-1 receptors for triple-negative breast cancer therapy},
  journal = {Journal of Materials Chemistry B},
  year = {2025},
  doi = {10.1039/d4tb02222j}
}
Kostenlos starten →